...
首页> 外文期刊>BMC Cancer >Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust
【24h】

Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust

机译:对大肠癌筛查的粪便潜血测试(FOBT)与粪便免疫化学测试(FIT)的态度:容易完成和令人恶心

获取原文
           

摘要

Background Colorectal cancer s creening is key to early detection and thus to early treatment, but uptake is often sub-optimal, particularly amongst lower income groups. It is proposed that the imminent introduction of the single-sample Faecal Immunochemical Test (FIT) in Scotland may lead to increased uptake as compared to the current Faecal Occult Blood Test (FOBT), but underlying reasons are yet to be determined. The aim was to evaluate attitudes and intentions towards completing the FIT compared to the current FOBT for colorectal cancer screening. Methods A convenience sample of 200 adults (mean age 56.5, range 40–89; 59?% female) living in Scotland rated both the FOBT and the FIT with regard to ease of completion, perceived disgust and intention to complete and return (all measured on Likert-type 1–7 scale). Participants were randomised to be presented (via a face-to-face contact) with either the FIT or FOBT first. Results Participants reported higher intention to complete and return the FIT versus the FOBT (mean difference 0.62, 95?% CI (0.44, 0.79)). Overall, 85.0?% ( n =?170) of participants agreed or strongly agreed that they would intend to complete and return the FIT compared to 65.5?% ( n =?131) for the FOBT (χ2?=?20.4, p Conclusions People reported higher intentions to complete and return a FIT than a FOBT test for colorectal cancer screening, largely due to a perception that it is easier and less disgusting to complete. The findings suggest that the introduction of the FIT as standard in the UK could result in a notable increase in screening uptake.
机译:背景大肠癌的增生是早期发现和早期治疗的关键,但是摄取通常不是最理想的,尤其是在低收入人群中。有人提出,与目前的粪便隐血试验(FOBT)相比,即将在苏格兰引入单一样品的粪便免疫化学试验(FIT)可能会导致摄入量增加,但是尚待确定根本原因。目的是评估与目前用于结肠直肠癌筛查的FOBT相比,完成FIT的态度和意图。方法在便利的样本中,居住在苏格兰的200名成年人(平均年龄56.5,年龄范围40-89;女性59%)对FOBT和FIT进行了评估,评估它们的容易程度,感觉上的厌恶以及完成和返回的意愿(均已测量)在Likert型1–7量表上)。参与者被随机分配为首先通过FIT或FOBT展示(通过面对面接触)。结果参与者报告说,与FOBT相比,完成和返回FIT的意愿更高(平均差异0.62,95%CI(0.44,0.79))。总体而言,有85.0%(n =?170)的参与者同意或强烈同意他们打算完成并返还FIT,而FOBT的比例为65.5%(n =?131)(χ 2 ?=?20.4,p结论与FOBT测试相比,人们报告完成和返回FIT的结直肠癌筛查意愿更高,这主要是因为人们认为,完成和返还FIT更容易,更不令人厌恶。在英国,FIT作为标准配置可能会导致筛查摄取显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号